CHO cell HCP customized development

CHO cell HCP customized development

Constream Biotech can provide customized development services for broad-spectrum or specific HCP reagents targeting different CHO cells (CHO-K1, CHO-S, CHO-DG44, etc.).


Constream Biotech can provide customized development services for broad-spectrum or specific HCP reagents targeting different CHO cells (CHO-K1, CHO-S, CHO-DG44, etc.).

Immunogenicity: Exogenous proteins such as PLBL2 and PRDX may pose immunogenicity risks.

Potential reduction in drug activity: Proteins with protease activity, such as Cathepsins, may degrade proteins.

Product degradation: HCPs from the lipase family, such as PPT1 and LPLA2, may degrade the formulation buffer Tween 20/80

Documents